These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23232049)

  • 1. Secukinumab failure in Crohn's disease: the yeast connection?
    Colombel JF; Sendid B; Jouault T; Poulain D
    Gut; 2013 May; 62(5):800-1. PubMed ID: 23232049
    [No Abstract]   [Full Text] [Related]  

  • 2. Seventeen in Crohn's disease: less prime than we thought?
    Raine T; Kaser A
    Gut; 2012 Dec; 61(12):1653-4. PubMed ID: 22689517
    [No Abstract]   [Full Text] [Related]  

  • 3. A Crohn's disease patient who does not respond to infliximab: what is next?
    Maharshak N; Plevy SE
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1033-8. PubMed ID: 21699811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-TNF therapy and Crohn's disease].
    Peyrin-Biroulet L
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):478-81. PubMed ID: 18439777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical images in gastroenterology. Crohn's disease treated with Remicade].
    Villanueva-Sáenz E; Wiener Carrillo I; Bolaños-Badillo LE; Blanco-Lucio RM
    Rev Gastroenterol Mex; 2007; 72(4):381. PubMed ID: 18595330
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab for the prevention of postoperative recurrence in patients with multiple surgeries for Crohn's disease.
    Yamamoto T
    Int J Colorectal Dis; 2012 Dec; 27(12):1681. PubMed ID: 22430891
    [No Abstract]   [Full Text] [Related]  

  • 7. Every fourth patient with Crohn's disease has anti-TNF dependency.
    Molnár T; Farkas K; Nyári T; Nagy F; Szepes Z; Wittmann T
    Aliment Pharmacol Ther; 2011 Aug; 34(3):400-1. PubMed ID: 21726253
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes MB; Hamlin PJ
    Aliment Pharmacol Ther; 2012 Aug; 36(4):398. PubMed ID: 22803644
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
    Lopez-Sanroman A; Gisbert JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):498-9. PubMed ID: 22860615
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-TNF antibody therapy in Crohn's disease: the risk of a switch.
    Ricart E; Ordás I; Panés J
    Gut; 2012 Feb; 61(2):169-70. PubMed ID: 22068167
    [No Abstract]   [Full Text] [Related]  

  • 11. Duodenal Crohn's disease successfully treated with adalimumab.
    Tursi A
    Endoscopy; 2011; 43 Suppl 2 UCTN():E22. PubMed ID: 21271523
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
    Tursi A; Elisei W; Picchio M; Penna A
    Aliment Pharmacol Ther; 2013 Apr; 37(7):763-4. PubMed ID: 23458543
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of recurrent Crohn's uveitis with infliximab.
    Ally MR; Veerappan GR; Koff JM
    Am J Gastroenterol; 2008 Aug; 103(8):2150-1. PubMed ID: 18796120
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide].
    Cabriada JL; García Sánchez V; Gomollón F; Hinojosa J; López San Román A; Mendoza JL; Mínguez M; Ricart E; Saro C
    Gastroenterol Hepatol; 2008 Dec; 31(10):693-7. PubMed ID: 19174086
    [No Abstract]   [Full Text] [Related]  

  • 15. Natalizumab (Tysabri) for Crohn's disease.
    Med Lett Drugs Ther; 2008 May; 50(1285):34-6. PubMed ID: 18458669
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease.
    Tursi A
    Dig Liver Dis; 2006 Jun; 38(6):439-40. PubMed ID: 16563889
    [No Abstract]   [Full Text] [Related]  

  • 17. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y; Debbeche R; Hamzaoui L; Lounissi M; Trabelsi S; Bouzaidi S; Salem M; Abdelmoula L; Najjar T
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract]   [Full Text] [Related]  

  • 18. Esophageal Crohn's disease treated successfully with adalimumab.
    Kwan LY; Conklin JL; Papadakis KA
    Inflamm Bowel Dis; 2007 May; 13(5):639-40. PubMed ID: 17221856
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammatory polypoid mass treated with Infliximab in a Crohn's disease patient.
    Liatsos C; Kyriakos N; Panagou E; Karagiannis S; Salemis N; Mavrogiannis C
    J Crohns Colitis; 2010 Dec; 4(6):707-8. PubMed ID: 21122587
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg?
    Magro F; Coelho R; Guimarães LS; Silva M; Peixoto A; Lopes S; Macedo G
    Scand J Gastroenterol; 2016; 51(4):511-2. PubMed ID: 26523855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.